SANTA CLARA, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of unified data and cloud analytics for the semiconductor ecosystem, today announced financial results for its third quarter ended September 30, …
New York Festivals® 2023 Radio Awards competition welcomes Diego Cannizzaro to the NYF Radio Awards Advisory Board. NEW YORK, NEW YORK, USA, November 10, 2022 /EINPresswire.com/ -- New York Festivals® 2023 Radio Awards competition welcomes Diego …
Attorney B'Ivory LaMarr and Legal Team Demand Transparency after 21-Year-Old Mysteriously Dies Less Than Two Hours after being Taken to Milwaukee Jail MILWAUKEE, WISCONSIN, UNITED STATES OF AMERICA, November 10, 2022 /EINPresswire.com/ -- A …
Presented New Preclinical Data at Recent Medical Meetings Showing Disease-Modifying Potential of Brain Penetrant Small Molecule Parkinson’s Disease Therapeutic, GT-02287 Promoted Matthias Alder to Chief Executive Officer and Appointed him to the Board of …
DELAWARE, Ohio, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced that it will participate in small group meetings at the following investor conferences: November 15, 2022 - Stephens …
– Initiated a randomized Phase 2 trial evaluating anti-TIGIT monoclonal antibody EOS-448/GSK4428859A and GSK’s anti-PD-1 Jemperli (dostarlimab) in first line, metastatic non-small cell lung cancer – Phase 2 trials with novel combinations underway for …
PITTSBURGH, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL), the world’s leading mobile learning platform, announced results for the third quarter ended September 30, 2022 in a shareholder letter that is posted at investors.duolingo.com. “ …
WAYNE, Pa., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the company will …
NASHVILLE, Tenn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the oral care company with the first medtech platform for teeth straightening, today announced that management is scheduled to speak at three upcoming conferences in …
Q3 Total Revenue Increased 11% Year-over-Year to $88.4 million Q3 Gross Merchandise Value Increased 7% Year-over-Year to $475.6 million Q3 Adjusted EBITDA was ($8.0) million with (9.0%) margins REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- …
HAMPTON, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following investor conferences in November: Guggenheim 4th Annual Immunology and Neurology …
ORLANDO, Fla., Nov. 10, 2022 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, reported its financial and operational results for the third …
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. (“Silver Spike” or the “Company”), a specialty finance company that was formed to invest across the cannabis ecosystem through investments in the form of direct loans to, and equity …
CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the …
CAMBRIDGE, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare and genetically defined diseases, today announced that the European Commission (EC) …
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, Nov. …
Delivers Record Revenue Growth and Significant Margin Improvement Raises 2022 Full Year Guidance for both Revenue and Adjusted EBITDA SAN FRANCISCO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Wag! Group Co. (the "Company” or “Wag!”; Nasdaq: PET), which …
Novel monoclonal antibody combination candidate (NVD200) on track to advance into clinical trials in Q1 2023 $419 million in cash, cash equivalents and marketable securities expected to support operating runway into Q2 2024 Conference call scheduled for …
NASHUA, N.H., Nov. 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the first step in the development of a new strategic multi-year …
Revenue for the first nine months of 2022 increased 26% to $57.7 million versus the same period in 2021 of $45.6 million DFD-29 Phase 3 studies are 75% enrolled to date Top-line data from the Phase 3 clinical program evaluating DFD-29 for the treatment of …
